American Century Companies
XERS icon

American Century Companies’s Xeris Biopharma Holdings XERS Stock Holding History

American Century Companies’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$739K Buy
+93,345
New +$596K ﹤0.01% 2493

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

American Century Companies's XERS Position: Q2 2026 in Review

American Century Companies opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 93,345 shares worth $739K. The stake represents ﹤0.01% of the portfolio and ranks #2493 among its holdings.

156 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • American Century Companies held 93,345 shares of Xeris Biopharma Holdings worth $739K as of Q2 2026.
  • Xeris Biopharma Holdings was a new American Century Companies position in Q2 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2493 holding.
  • 156 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.